Renal transplantation today

  • Michael Neipp
  • Steffan Jackobs
  • Jürgen Klempnauer
Current Concepts in Clinical Surgery

Abstract

Background

The first successful renal transplant was carried out more than five decades ago between identical twins. At these early days, acute rejection was the limiting factor.

Discussion

Due to tremendous progress in immunosuppressive therapy and surgical technique, today, renal transplantation is the gold standard therapy for patients with end-stage renal disease. In fact, in comparison with chronic hemodialysis, renal transplantation offers an increase in quality of life while reducing comorbidities associated with dialysis treatment.

Results

Despite numerous beneficial achievements, no further improvement regarding patient outcome can be observed over the last two decades. Graft survival rates remain unchanged. The leading causes for graft loss are chronic allograft nephropathy and death with functioning graft. This might be related to a constant increase of the proportion of donors presenting extended donor criteria as well as a more liberal acceptance of candidates for a renal transplant.

Conclusion

In the near future, one has to focus more closely on the posttransplant patient care to minimize factors associated with chronic allograft damage. These include post-transplant diabetes, hyperlipidemia, high blood pressure, cytomegalovirus infection, etc.

Keywords

Renal transplantation Surgical technique Immunosuppression Living donation Donor selection Prophylaxis Complications Outcome 

References

  1. 1.
    Lück R, Schrem H, Neipp M, Nashan B, Klempnauer J (2003) Living kidney transplantation. A comparison of Scandinavian countries and Germany. Chirurg 74(6):523PubMedCrossRefGoogle Scholar
  2. 2.
    Ratner LE, Ciseck LJ, Moore RG, Cigarroa FG, Kaufman HS, Kavoussi LR (1995) Laparoscopic live donor nephrectomy. Transplantation 60(9):1047PubMedGoogle Scholar
  3. 3.
    Jones KW, Peters TG, Walker GW (1999) Anterior-retroperitoneal living donor nephrectomy: technique and outcomes. Am Surg 65(3):197PubMedGoogle Scholar
  4. 4.
    Velidedeoglu E, Williams N, Brayman KL et al (2002) Comparison of open, laparoscopic, and hand-assisted approaches to live-donor nephrectomy. Transplantation 74(2):169PubMedCrossRefGoogle Scholar
  5. 5.
    Yang SL, Harkaway R, Badosa F, Ginsberg P, Greenstein MA (2002) Minimal incision living donor nephrectomy: improvement in patient outcome. Urology 59(5):673PubMedCrossRefGoogle Scholar
  6. 6.
    Perry KT, Freedland SJ, Hu JC et al (2003) Quality of life, pain and return to normal activities following laparoscopic donor nephrectomy versus open mini-incision donor nephrectomy. J Urol 169(6):2018PubMedCrossRefGoogle Scholar
  7. 7.
    Greenstein MA, Harkaway R, Badosa F, Ginsberg P, Yang SL (2003) Minimal incision living donor nephrectomy compared to the hand-assisted laparoscopic living donor nephrectomy. World J Urol 20(6):356PubMedGoogle Scholar
  8. 8.
    Neipp M, Jackobs S, Becker T et al (2004) Living donor nephrectomy: flank incision versus anterior vertical mini-incision. Transplantation 78(9):1356PubMedCrossRefGoogle Scholar
  9. 9.
    Jackobs S, Becker T, Luck R et al (2005) Quality of life following living donor nephrectomy comparing classical flank incision and anterior vertical mini-incision. World J Urol 23:343PubMedCrossRefGoogle Scholar
  10. 10.
    Gregoir W, Schulman CC (1977) Extravesical antirefluxplasty. Urologe 16(3):124PubMedGoogle Scholar
  11. 11.
    Neipp M, Becker T, Jackobs S et al Nierentransplantation nach Lebendspende: Ergebnisse von Organen mit anatomischen Variationen. 14. Jahrestagung der Deutschen Transplantationsgesellschaft, Rostock, Germany: Transplantationsmedizin, 2005: 23Google Scholar
  12. 12.
    Neipp M, Jackobs S, Jaeger M et al (2006) Living kidney donors >60 years of age: is it acceptable for the donor and the recipient? Transpl Int 19(3):213PubMedCrossRefGoogle Scholar
  13. 13.
    Qvist E, Narhi V, Apajasalo M et al (2004) Psychosocial adjustment and quality of life after renal transplantation in early childhood. Pediatr Transplant 8(2):120PubMedCrossRefGoogle Scholar
  14. 14.
    Pape L, Ehrich JH, Zivicnjak M, Offner G (2005) Growth in children after kidney transplantation with living related donor graft or cadaveric graft. Lancet 366(9480):151PubMedCrossRefGoogle Scholar
  15. 15.
    Offner G, Latta K, Hoyer PF (1991) CAPD in children with special aspects of renal transplantation. Contrib Nephrol 89:243PubMedGoogle Scholar
  16. 16.
    Latta K, Offner G, Brodehl J (1992) Continuous peritoneal dialysis in children. Adv Perit Dial 8:406PubMedGoogle Scholar
  17. 17.
    Neipp M, Offner G, Luck R et al (2002) Kidney transplant in children weighing less than 15 kg: donor selection and technical considerations. Transplantation 73(3):409PubMedCrossRefGoogle Scholar
  18. 18.
    Becker T, Neipp M, Reichart B et al (2006) Paediatric kidney transplantation in small children– a single centre experience. Transpl Int 19(3):197PubMedCrossRefGoogle Scholar
  19. 19.
    Pape L, Hoppe J, Becker T et al (2006) Superior long-term graft function and better growth of grafts in children receiving kidneys from paediatric compared with adult donors. Nephrol Dial Transplant 21(9):2596PubMedCrossRefGoogle Scholar
  20. 20.
    Loirat C, Chalem Y, Golmard JL (2001) Organ allocation in pediatric transplantation in France. Pediatr Nephrol 16(12):964PubMedCrossRefGoogle Scholar
  21. 21.
    Tyden G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman I (2005) ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 5(1):145PubMedCrossRefGoogle Scholar
  22. 22.
    Ahlenstiel T, Offner G, Strehlau J et al (2006) ABO-incompatible kidney transplantation of an 8-yr-old girl with donor/recipient-constellation A1B/B. Xenotransplantation 13(2):141PubMedCrossRefGoogle Scholar
  23. 23.
    Radermacher J, Mengel M, Ellis S et al (2003) The renal arterial resistance index and renal allograft survival. N Engl J Med 349(2):115PubMedCrossRefGoogle Scholar
  24. 24.
    Mengel M, Gwinner W, Schwarz A et al (2007) Infiltrates in protocol biopsies from renal allografts. Am J Transplant 7(2):356PubMedCrossRefGoogle Scholar
  25. 25.
    Schwarz A, Mengel M, Gwinner W et al (2005) Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study. Kidney Int 67(1):341PubMedCrossRefGoogle Scholar
  26. 26.
    Rush DN, Jeffery JR, Gough J (1995) Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schema. Transplantation 59(4):511PubMedGoogle Scholar
  27. 27.
    Schlitt HJ, Hoffmann MW (2001) Reconstruction of necrotic kidney graft pelvis with a vascularized small bowel patch. Transpl Int 14(2):95PubMedCrossRefGoogle Scholar
  28. 28.
    Mengel M, Chapman JR, Cosio FG et al (2007) Protocol Biopsies in Renal Transplantation: Insights into Patient Management and Pathogenesis. Am J Transplant 7:512–517PubMedCrossRefGoogle Scholar
  29. 29.
    Hardinger KL, Schnitzler MA, Koch MJ et al (2006) Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience. Transplantation 81(9):1285PubMedCrossRefGoogle Scholar
  30. 30.
    Qiu J, Cai J, Terasaki PL Death with a functioning graft in kidney transplant recipients. Clin Transpl 2004:379–386Google Scholar
  31. 31.
    Schiel R, Heinrich S, Steiner T, Ott U, Stein G (2005) Post-transplant diabetes mellitus: risk factors, frequency of transplant rejections, and long-term prognosis. Clin Exp Nephrol 9(2):164PubMedCrossRefGoogle Scholar
  32. 32.
    Joss N, Staatz CE, Thomson AH, Jardine AG (2007) Predictors of new onset diabetes after renal transplantation. Clin Transplant 21(1):136PubMedCrossRefGoogle Scholar
  33. 33.
    Salvadori M, Bertoni E, Rosati A, Zanazzi M (2003) Post-transplant diabetes mellitus. J Nephrol 16(5):626PubMedGoogle Scholar
  34. 34.
    Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ (2003) Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3(2):178PubMedCrossRefGoogle Scholar
  35. 35.
    Eypasch E, Wood-Dauphinee S, Williams JI, Ure B, Neugebauer E, Troidl H (1993) The Gastrointestinal Quality of Life Index. A clinical index for measuring patient status in gastroenterologic surgery. Chirurg 64(4):264PubMedGoogle Scholar
  36. 36.
    Vitko S, Margreiter R, Weimar W et al (2005) Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients. Am J Transplant 5(10):2521PubMedCrossRefGoogle Scholar
  37. 37.
    Birkeland SA, Lokkegaard H, Storm HH (2000) Cancer risk in patients on dialysis and after renal transplantation. Lancet 355(9218):1886PubMedCrossRefGoogle Scholar
  38. 38.
    Penn I (1997) Evaluation of transplant candidates with pre-existing malignancies. Ann Transplant 2(4):14PubMedGoogle Scholar
  39. 39.
    Campistol JM, Gutierrez-Dalmau A, Torregrosa JV (2004) Conversion to sirolimus: a successful treatment for posttransplantation Kaposi’s sarcoma. Transplantation 77(5):760PubMedCrossRefGoogle Scholar
  40. 40.
    Stallone G, Schena A, Infante B et al (2005) Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med 352(13):1317PubMedCrossRefGoogle Scholar
  41. 41.
    Fischer A, Blanche S, Le Bidois J et al (1991) Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 324(21):1451PubMedGoogle Scholar
  42. 42.
    Luan FL, Ding R, Sharma VK, Chon WJ, Lagman M, Suthanthiran M (2003) Rapamycin is an effective inhibitor of human renal cancer metastasis. Kidney Int 63(3):917PubMedCrossRefGoogle Scholar
  43. 43.
    Guba M, Graeb C, Jauch KW, Geissler EK (2004) Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 77(12):1777PubMedCrossRefGoogle Scholar
  44. 44.
    Fujisawa M, Ichikawa Y, Yoshiya K et al (2000) Assessment of health-related quality of life in renal transplant and hemodialysis patients using the SF-36 health survey. Urology 56(2):201PubMedCrossRefGoogle Scholar
  45. 45.
    Neipp M, Karavul B, Jackobs S et al (2006) Quality of life in adult transplant recipients more than 15 years after kidney transplantation. Transplantation 81(12):1640PubMedCrossRefGoogle Scholar
  46. 46.
    Bullinger M (2000) Erfassung der gesundheitsbezogenen Lebensqualität mit dem SF-36 Health Survey. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 43:190CrossRefGoogle Scholar
  47. 47.
    Laupacis A, Pus N, Muirhead N, Wong C, Ferguson B, Keown P (1993) Disease-specific questionnaire for patients with a renal transplant. Nephron 64(2):226PubMedCrossRefGoogle Scholar
  48. 48.
    Hagenmeyer EG, Haussler B, Hempel E et al (2004) Resource use and treatment costs after kidney transplantation: impact of demographic factors, comorbidities, and complications. Transplantation 77(10):1545PubMedCrossRefGoogle Scholar
  49. 49.
    Shaffer D, Langone A, Nylander WA, Goral S, Kizilisik AT, Helderman JH (2003) A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function. Clin Transplant 17(Suppl 9):31PubMedCrossRefGoogle Scholar
  50. 50.
    Segoloni GP, Messina M, Squiccimarro G et al (2005) Preferential allocation of marginal kidney allografts to elderly recipients combined with modified immunosuppression gives good results. Transplantation 80(7):953PubMedCrossRefGoogle Scholar
  51. 51.
    Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D (2000) Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342(9):605PubMedCrossRefGoogle Scholar
  52. 52.
    Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B (2004) Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4(3):378PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Michael Neipp
    • 1
  • Steffan Jackobs
    • 1
  • Jürgen Klempnauer
    • 1
  1. 1.Klinik für Allgemein-, Viszeral- und TransplantationschirurgieMedizinische Hochschule HannoverHannoverGermany

Personalised recommendations